Literature DB >> 17450511

Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses.

Angela Clerk1, Timothy E Cullingford, Stephen J Fuller, Alejandro Giraldo, Thomais Markou, Sampsa Pikkarainen, Peter H Sugden.   

Abstract

The contractile cells in the heart (the cardiac myocytes) are terminally differentiated. In response to pathophysiological stresses, cardiac myocytes undergo hypertrophic growth or apoptosis, responses associated with the development of cardiac pathologies. There has been much effort expended in gaining an understanding of the stimuli which promote these responses, and in identifying the intracellular signaling pathways which are activated and potentially involved. These signaling pathways presumably modulate gene and protein expression to elicit the end-stage response. For the regulation of gene expression, the signal may traverse the cytoplasm to modulate nuclear-localized transcription factors as occurs with the mitogen-activated protein kinase or protein kinase B/Akt cascades. Alternatively, the signal may promote translocation of transcription factors from the cytoplasm to the nucleus as is seen with the calcineurin/NFAT and JAK/STAT systems. We present an overview of the principal signaling pathways implicated in the regulation of gene expression in cardiac myocyte pathophysiology, and summarize the current understanding of these pathways, the transcription factors they regulate and the changes in gene expression associated with the development of cardiac pathologies. Finally, we discuss how intracellular signaling and gene expression may be integrated to elicit the overall change in cellular phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17450511     DOI: 10.1002/jcp.21094

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  64 in total

1.  Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide.

Authors:  Eduardo Mascareno; Daniel Beckles; Manya Dhar-Mascareno; M A Q Siddiqui
Journal:  Vascul Pharmacol       Date:  2009-06-26       Impact factor: 5.773

2.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

Review 3.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

4.  The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin.

Authors:  Jinliang Li; Alejandra Negro; Johanna Lopez; Andrea L Bauman; Edward Henson; Kimberly Dodge-Kafka; Michael S Kapiloff
Journal:  J Mol Cell Cardiol       Date:  2009-10-31       Impact factor: 5.000

5.  Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells.

Authors:  Nynke E Hahn; René J P Musters; Jan M Fritz; Patrick J Pagano; Alexander B A Vonk; Walter J Paulus; Albert C van Rossum; Christof Meischl; Hans W M Niessen; Paul A J Krijnen
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

Review 6.  Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.

Authors:  Kaie Ojamaa
Journal:  Vascul Pharmacol       Date:  2009-12-11       Impact factor: 5.773

Review 7.  Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

Authors:  P H Sugden; S J Fuller; S C Weiss; A Clerk
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

8.  Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction.

Authors:  Elza D van Deel; Zhongbing Lu; Xin Xu; Guangshuo Zhu; Xinli Hu; Tim D Oury; Robert J Bache; Dirk J Duncker; Yingjie Chen
Journal:  Free Radic Biol Med       Date:  2007-12-15       Impact factor: 7.376

9.  ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes.

Authors:  Andrew K Marshall; Oliver P T Barrett; Timothy E Cullingford; Achchuthan Shanmugasundram; Peter H Sugden; Angela Clerk
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

10.  Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate.

Authors:  Jonathan C Trent; Shalin S Patel; Jianhu Zhang; Dejka M Araujo; Juan-Carlos Plana; Daniel J Lenihan; Dominic Fan; Shreyaskumar R Patel; Robert S Benjamin; Aarif Y Khakoo
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.